Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Upstream binding transcription factor, RNA polymerase I-like 8 (UBTFL8) is classified as a pseudogene in the human genome. Pseudogenes are segments of DNA resembling genes but typically lack the ability to code for functional proteins. UBTFL8 shows sequence similarity to the upstream binding transcription factor gene family, but is not expressed or characterized as functional. There is no evidence linking UBTFL8 to biological pathways, diseases, or drug interactions. Its abbreviation and name risk being confused with UBTF, an important transcription factor and leukemia research target, but UBTFL8 itself is not a clinically or experimentally validated target.
pseudogene, no function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream binding transcription factor, RNA polymerase I-like 8 (pseudogene) (UBTFL8).